Synchron’s brain implant lets an ALS patient control an iPad entirely through thought
FierceBiotech - 04-Aug-2025This breakthrough shows how technology can restore independence
Thomas Oxley
CEO of Synchron, Co-head Vascular Bionics laboratory at the University of Melbourne
Thomas Oxley is the chief executive officer of Synchron and neurointerventionist at Mount Sinai Hospital in New York City. Established the Vascular Bionics laboratory at the University of Melbourne and is currently co-head of this lab. Bachelor's degrees in medical science, medicine and surgery from the University of Monash in Melbourne Australia. Doctorate degrees in philosophy and neuroscience from the University of Melbourne.
Details last updated 09-Nov-2020
Thomas Oxley News
Synchron's BCI device offers new hope for communication in paralyzed patients
IEEE Spectrum - 20-Dec-2023Non-invasive neural device leads via blood vessel while Neuralink awaits human trials
Synchron’s brain implant that helps turn thoughts into text
CNBC - 18-Feb-2023Stentrode is an endovascular electrode array implanted through the blood vessels
Synchron helps paralysed patients control digital devices with thoughts alone
MobiHealthNews - 29-Jul-2021Implantable brain computer interface received FDA approval for human trials in US
Scientists connect brains and computers through veins
Independent - 04-Nov-2020A less invasive approach of brain-computer interface than Neuralink
